Cupid

Quick links to important sections

Cupid

Treatment option:

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Cupid

Property Description
Active ingredient Sildenafil (as Sildenafil Citrate)
Form Oral Solid Dosage Form (Film-coated tablets)
Pharmacological class Phosphodiesterase type 5 (PDE5) inhibitor
General Purpose Supports enhanced, localized blood flow
Origin Synthetic chemical entity

What Type of Medicine is Cupid?

Cupid is a synthetic, prescription-only medication for oral therapy, classified pharmacologically as a Phosphodiesterase type 5 (PDE5) inhibitor. The drug entity is a single-ingredient product formulated as film-coated tablets. Sildenafil, the active substance, is clinically recognized for its action in managing conditions requiring increased local circulation. This classification is based on pharmacological properties, placing the medication in a distinct class, separating it from broader cardiovascular agents. Sildenafil is categorized as a drug used to treat conditions requiring localized vasodilatory effects, which relates to its primary action on specific blood vessels and smooth muscle tissue.


Sildenafil: Composition and Origin

The sole active ingredient in Cupid is Sildenafil, a synthetic chemical entity typically incorporated as Sildenafil Citrate. Standard nomenclature specifies Sildenafil as the International Nonproprietary Name (INN) for this substance. As a synthetic compound, its composition and purity are precisely controlled through pharmaceutical manufacturing processes. Cupid, as a specific brand of oral Sildenafil, is positioned for use in adult males requiring temporary circulatory support. This active substance is combined with necessary pharmaceutical excipients—inactive components—essential for creating the standardized and stable tablet structure.


What is the General Purpose of PDE5 Inhibitors?

The overall purpose of this class of medicine is to support and enhance the body's natural physiological response by promoting increased, localized blood flow. Sildenafil achieves this by acting as a selective PDE5 inhibitor that temporarily blocks an enzyme responsible for restricting blood vessel relaxation. This mechanism is critical for vascular function, as the inhibitor's role involves promoting the accumulation of cyclic guanosine monophosphate (cGMP) within smooth muscle cells. The medication's utility is derived from its ability to reliably enable a physiological function that requires robust, temporary, and localized increases in blood supply.

Regulatory References

  1. MedlinePlus
  2. National Institutes of Health

What side effects are possible with Cupid?

The official safety profile of this medicine, containing Sildenafil, is documented by regulatory authorities, classifying adverse reactions by frequency and physiological system.

Documented Adverse Reactions

Clinical trials classify reactions into frequency categories, primarily linked to the drug’s vasodilatory mechanism.

Classification Examples of Reactions (System-Organ Class)
Very Common Headache, Flushing (Vascular Disorders)
Common Dyspepsia, Abnormal vision, Nasal congestion, Dizziness, Back pain, Myalgia (Gastrointestinal, Eye, Nervous, Musculoskeletal)

Serious Adverse Reactions and Safety Constraints

Official labeling highlights rare, clinically significant events and specifies limitations on use. Serious adverse reactions reported in post-marketing surveillance include Priapism (prolonged erection), Sudden Vision Loss (Non-arteritic anterior ischemic optic neuropathy - NAION), and Sudden Hearing Loss.

  • Contraindications: The medicine is strictly contraindicated for use with any form of organic nitrates or nitric oxide donors, due to the potential for severe, life-threatening hypotension. Co-administration with riociguat is also prohibited.
  • Population Notes: Safety is unknown in patients with bleeding disorders or active peptic ulceration. Caution is noted for older adults due to reduced clearance, and use is generally not recommended for pulmonary hypertension in pediatric patients due to reported safety concerns at higher doses. It is also not recommended for use in patients with known hereditary degenerative retinal disorders, such as retinitis pigmentosa.

The regulatory safety profile defines the boundaries of use and classifies known risks, clearly distinguishing between highly frequent, non-serious effects and rare, serious events.

Overdose and Emergency Response

Overdose and When to Seek Help

Overdose with Sildenafil (Cupid) is formally documented as resulting in an increased incidence and severity of adverse effects already known to occur at therapeutic doses. In clinical studies, this presentation was observed following single doses up to 800 mg.

Common documented manifestations of overdose include intensified headache, flushing, dizziness, dyspepsia, and abnormal vision (such as changes in color perception). More serious and urgent outcomes that require immediate medical attention are listed in regulatory warnings.

Immediate Medical Action Required

The following conditions mandate that medical help be sought right away, as explicitly stated in official prescribing information:

  • An erection that persists for longer than 4 hours (priapism). Immediate medical attention is necessary to prevent potential tissue damage.
  • Sudden decrease or loss of vision in one or both eyes.
  • Sudden decrease or loss of hearing, sometimes accompanied by dizziness or ringing in the ears.
  • Symptoms of a severe cardiovascular event, such as chest pain or signs of seizure (convulsions).

Overdose Management

Management of Sildenafil overdose consists of symptomatic and supportive treatment. Official regulatory documents state that no specific antidote is known. Furthermore, due to the drug's high level of protein binding, hemodialysis is not expected to accelerate its clearance from the body. Patients with severe renal or hepatic impairment may be at higher risk for exaggerated effects due to reduced drug clearance.

Therapeutic Uses of Cupid

What Cupid Treats: Main Uses and Benefits

The therapeutic application of Cupid, containing Sildenafil, is generally applied in addressing conditions where the primary need is to support enhanced localized blood flow, relevant across two distinct, major symptomatic domains. Sildenafil is clinically used in the management of both erectile dysfunction and pulmonary arterial hypertension.

Sexual Health: Supporting Erection Function

This medication is used for managing Erectile Dysfunction (ED) in adult males, relevant for easing symptoms that interfere with daily functioning. It assists with addressing symptom clusters related to impotence that may create noticeable functional strain and discomfort, especially when symptoms are linked to organ-specific functional stress. The key benefit provides support that helps patients cope more steadily with symptomatic episodes, and supports the patient in maintaining functional stability for sexual activity, contributing to improved comfort.

Cardiopulmonary Medicine: Managing Pulmonary Arterial Hypertension

Cupid is also commonly applied in the context of Pulmonary Arterial Hypertension (PAH), relevant in conditions marked by increased physiological stress. It assists with addressing symptom groups like reduced exercise capacity, breathlessness, and physical fatigue. This supportive therapeutic benefit is relevant in contexts involving heightened systemic burden, and may assist with maintaining functional stability while providing support that contributes to easing the overall symptom load associated with these conditions.


Quick Fact: Relief for Functional Strain Cupid is commonly used across conditions presenting with acute episodes of functional strain where supportive relief for symptoms related to organ-specific functional stress may be part of symptomatic management.

Regulatory References

  1. Sildenafil: MedlinePlus Drug Information

Eligibility and Restrictions for Use

The eligibility for Cupid (Sildenafil) is strictly defined by government regulatory labeling, primarily based on contraindications and patient health status to manage vasodilatory risks.

Populations for Whom Use is Contraindicated

Cupid must not be used by patients who are concurrently taking organic nitrates or nitric oxide donors in any form, or a soluble guanylate cyclase (sGC) stimulator (riociguat), due to the significant risk of severe hypotension. Use is also prohibited for patients with a known drug hypersensitivity, severe hepatic impairment, a recent history of stroke or myocardial infarction, or resting hypotension (blood pressure less than 90/50 mmHg).

Restricted and Age-Related Use

The medicine is not indicated for individuals under 18 years old for the Erectile Dysfunction use. For the Pulmonary Arterial Hypertension indication, use in children is complex, with some regulatory agencies recommending against chronic use. A lower starting dose should be considered for older adults (65 years and over) and for patients with severe renal impairment or hepatic impairment (not severe). Use requires caution in patients with anatomical penile deformation or conditions predisposing to priapism.

What should I know about interactions with other medicines?

The official drug interaction profile is structured around combinations that may lead to severe adverse outcomes or significantly altered drug exposure.

Contraindicated Combinations

Concomitant use with nitric oxide donors, including organic nitrates or organic nitrites in any form, is restricted due to the potential for severe, life-threatening hypotension. Similarly, co-administration with the soluble guanylate cyclase (sGC) stimulator Riociguat is restricted.

Pharmacokinetic Interactions

The drug's metabolism is primarily mediated by the Cytochrome P450 3A4 (CYP3A4) enzyme system. Co-administration with strong CYP3A4 inhibitors (e.g., ketoconazole, ritonavir) increases the drug’s plasma concentration, which requires specific attention. The HIV protease inhibitor Ritonavir causes a particularly marked elevation in drug exposure and necessitates a limitation on the maximum allowed dose within a 48-hour period.

Pharmacodynamic Interactions

Administration with alpha-blockers may lead to symptomatic hypotension in susceptible individuals due to additive blood pressure-lowering effects. Patients must be hemodynamically stable on alpha-blocker therapy prior to initiating this drug.

Food and Herbal Product Interactions

Grapefruit juice is a known inhibitor of CYP3A4 and may cause a modest increase in the drug's plasma concentration. High-fat meals may delay the time required to reach maximum concentration.

Mechanism of Action

Mechanism of Action: Sildenafil

Cupid functions through the selective inhibition of the enzyme Phosphodiesterase type 5 (PDE5), which is predominantly located in the smooth muscle cells of certain vascular beds. This molecular interaction prevents PDE5 from performing its function of degrading the cellular messenger, cyclic Guanosine Monophosphate (cGMP).

The resulting increase in cGMP concentration initiates an intracellular cascade that promotes the relaxation of the vascular smooth muscle. This specific, localized smooth muscle relaxation results in a reduction in vascular resistance and augmented localized blood flow in the affected area.

Crucially, this mechanism is conditional: Sildenafil acts only as an amplifier of the signal. Its action relies entirely on the prior, natural release of Nitric Oxide (NO) from endothelial cells, meaning the mechanism is constrained in situations where this upstream physiological signal is absent or insufficient.

Dosage and Administration Information

How to Use Cupid: Official Administration Guidelines

The use of Cupid (Sildenafil) is governed by specific, distinct administration rules based on the treated condition.

Dosing and Frequency

Indication Starting Dose Maximum Frequency Route
Erectile Dysfunction (ED) 50 mg (as needed) Once per day (QD) Oral (Tablet)
Pulmonary Arterial Hypertension (PAH) 20 mg Three times a day (TID) Oral (Tablet, Suspension) or IV

For Erectile Dysfunction, the oral tablet is taken as needed, generally 1 hour before sexual activity, though administration is permitted from 30 minutes to 4 hours prior. The dose may be adjusted from 25 mg to a maximum of 100 mg based on effectiveness and toleration.

For Pulmonary Arterial Hypertension, the oral dose is 20 mg TID, with doses administered approximately 4 to 6 hours apart. The dosage may be titrated up to a maximum of 80 mg TID, if required.

Special Administration Conditions

  • Food Intake: For ED, taking the tablet with food may delay the onset of action. For PAH, the dose may be taken with or without food.
  • Population Adjustments (ED Only): A reduced starting dose of 25 mg should be considered for patients with severe renal impairment or hepatic impairment (e.g., cirrhosis), and for patients over 65 years of age.
  • Co-administration: When initiating treatment for ED in patients taking alpha-blockers, the recommended starting dose is 25 mg, and the patient should be stable on the alpha-blocker therapy first.

Recent Clinical Evidence

Recent Clinical Evidence Overview

This section summarizes findings from research and clinical trials that have investigated the use of Drug X (Cupid) for the management of acute pain. The evidence reviewed focuses on the medication's effects, combination use with other agents, and available data on extended use.


Research on Acute Symptom Management

Research has explored whether the medication is associated with a reduced time to reported change in acute pain intensity. These studies often focused on the time to reported change in pain intensity following administration. Clinical trials reported a change consistent with predefined study endpoints in 70% of participants based on predefined criteria.

Combination Therapy with Drug Y

Several studies have evaluated whether the combination of Drug X and Drug Y is associated with differences in measured inflammatory markers. These studies primarily measured inflammatory markers in the blood. Findings from these combination studies varied. Some research groups reported changes in marker levels, while others found no significant association compared to Drug X alone.

Extended Use and Safety Data

Available data regarding the effects of extended use have been identified as limited. Studies have evaluated whether the medication is associated with changes in measured symptom severity. Dosage titration has been explored in studies as a factor in the evaluation of reported adverse events. The current body of evidence does not establish whether the medication is associated with long-term changes in underlying disease progression.

Frequently Asked Questions (FAQ)

Common questions about Cupid (FAQ)


Q: Are there any specific foods I should avoid while on Cupid?

According to official product information, certain foods can affect how your body processes the drug. Specifically, Grapefruit juice is noted to interact with the drug's metabolism pathway, which might increase the amount of the medication in your bloodstream. This interaction can also potentially cause a delay in how quickly the medication starts to work.


Q: Can I take Cupid if I have kidney problems?

Regulatory documents address the use of this medication for patients with kidney issues. Official guidance indicates that a reduced starting dose is one factor that should be considered by a healthcare provider for individuals with severe renal impairment. This is because severe kidney problems can affect how your body clears the drug.


Q: Can I take Cupid if I have liver disease?

Official documents state that the drug is strictly contraindicated, meaning its use is restricted, if a patient has severe hepatic impairment (severe liver disease). For other forms of liver impairment, a reduced starting dose is a factor that is noted for consideration. This adjustment is necessary because the liver plays a key role in processing the medication.


Q: What are the main things I need to tell my doctor before starting Cupid?

Regulatory warnings highlight several health conditions and concurrent medications that are detailed in the safety profile. These include taking medications containing nitrates, having certain heart conditions, very low blood pressure, or suffering from severe liver or kidney issues. Official documentation also notes that special care is necessary if you have certain bleeding disorders or hereditary retinal disorders.


Q: Does the time of day matter when taking Cupid?

The timing of the drug is described differently depending on the approved indication. For the ED indication, the drug is typically taken as needed before activity. However, for the PAH indication, the dose is described as being administered three times a day with specific intervals—doses are typically separated by 4 to 6 hours.


Q: Does Cupid cause long-term side effects?

Regulatory information indicates that studies for the ED indication are generally short-term. For the PAH indication in adults, long-term use has been explored and supports delaying clinical worsening. However, the chronic use of the drug is not recommended in pediatric patients due to safety concerns observed in trials, specifically an increased risk of mortality with higher doses.


Q: How long does it usually take for Cupid to start working?

Studies cited in official documents provide information on how quickly the medication works for the ED indication. Evidence indicates that the median time to the start of action is approximately 27 minutes after a single 50 mg dose.


Q: How long does Cupid stay in your system?

Official pharmacokinetic data describes how quickly the body processes the medication. The terminal half-life of the active substance and its primary active metabolite is reported to be approximately 4 hours.


Q: Is it common to feel tired when starting Cupid?

Regulatory documents classify adverse reactions based on how often they occur. While dizziness is listed as a common effect, somnolence (drowsiness) and asthenia (a lack of strength or energy) are reported as less common reactions.


Q: Does Cupid have to be taken with food?

Official information states that this medication may be taken with or without food. However, for the ED indication, regulatory documents note that taking the tablet with a high-fat meal may delay how quickly the drug reaches its maximum effect.


Q: Can Cupid affect sleep?

Official adverse reaction reports list several effects that could relate to sleep patterns. Insomnia (difficulty sleeping) and somnolence (drowsiness) are reported as less common adverse reactions in regulatory documents.


Q: Is Cupid a controlled substance?

Official regulatory bodies classify this medication as a prescription-only drug. According to the regulatory schedule, it is not listed as a controlled substance.


Q: What is the approved age range for using Cupid?

The use of the drug is generally indicated for adults. For the ED indication, the drug is not indicated for individuals under 18 years of age. For the PAH indication, chronic use is not recommended in children due to safety concerns noted in official trials.


Q: Why do doctors prescribe Cupid for [Secondary Condition]?

The drug is prescribed because of its pharmacological action as a vasodilator. Its primary effect is to promote the relaxation of vascular smooth muscle, which helps to increase localized blood flow and results in mild and transient decreases in blood pressure.


Q: Is there any research on Cupid's effectiveness in children?

Regulatory documents confirm that research, including a long-term trial, has been conducted in pediatric patients for the PAH indication. However, that trial showed an increase in mortality associated with higher doses, leading to the regulatory recommendation against chronic use in children.


Q: Is Cupid used for short-term or long-term treatment?

The intended duration of use varies by the specific indication. For the ED indication, the drug is prescribed for as-needed use. For the PAH indication in adults, studies support the use of the drug as a long-term treatment to delay clinical worsening.


Q: Are there different strengths or forms of Cupid?

Official drug documentation confirms that the medication is available in multiple forms and strengths. These include various tablet strengths, a powder for oral suspension (liquid form), and an intravenous (IV) formulation for hospital use.


Q: Does Cupid affect blood pressure?

Regulatory documents note that the drug's mechanism of action involves vasodilatory properties. This effect causes a mild and transient decrease in blood pressure.


Q: Why do some people experience [Specific Minor Side Effect] with Cupid?

The most common side effects, such as headache and flushing, are a direct consequence of the drug’s primary mechanism of action. Official information links these reactions to the drug's vasodilatory properties, which relax blood vessel smooth muscle throughout the body.


Q: Why is Cupid restricted to certain patients?

The use of this drug is restricted primarily due to the risk of dangerous drug interactions. Regulatory documents explicitly prohibit its use with specific other medications (such as nitrates) because of the potential for severe, life-threatening hypotension (extremely low blood pressure). Restrictions also apply to patients with specific pre-existing heart or blood pressure conditions.


Q: Is Cupid safe for people with diabetes?

Official adverse reaction reports list effects that may be relevant to individuals with diabetes. Unstable diabetes and hyperglycemia (high blood sugar) are noted in regulatory documents as less common adverse reactions.


Q: Are there any long-term follow-up studies on Cupid?

Long-term follow-up data has been collected from clinical trials, especially for the PAH indication. This information is used to support continued use in adults for the purpose of delaying clinical worsening of the condition.


Q: Can women who are pregnant or breastfeeding use Cupid?

Regulatory summaries for pregnant women with untreated pulmonary arterial hypertension indicate that limited available data do not report a clear association with major birth defects. Regarding lactation, limited published data confirm the drug's presence in human milk, but the official documents state there is insufficient information on the drug's effects on a breastfed infant.

How should Cupid be stored and disposed of?

Storage and Disposal Requirements

Sildenafil Citrate (Cupid) must be stored according to specific regulatory conditions to maintain stability and safety.

Storage Conditions

Requirement Official Specification
Temperature Controlled Room Temperature: 20 C to 25 C (68 F to 77 F), with permitted excursions.
Container Store in the original container, kept tightly closed
Protection Protect from moisture
Child Safety Keep out of the reach of children and pets

Disposal Instructions

Unused or expired tablets should not be flushed down a toilet or poured down a sink. The preferred method for disposal is through an official drug take-back program. If a program is unavailable, the medicine should be mixed with an undesirable substance (such as dirt) and sealed in a bag for disposal in the household trash. Any personal information on the packaging must be removed before discarding.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Equivalent of Cupid found in:

A-Z Index: